PL2682409T3 - Pochodna kwasu hialuronowego zmodyfikowana kwasem aminokarboksylowym - Google Patents
Pochodna kwasu hialuronowego zmodyfikowana kwasem aminokarboksylowymInfo
- Publication number
- PL2682409T3 PL2682409T3 PL12752403T PL12752403T PL2682409T3 PL 2682409 T3 PL2682409 T3 PL 2682409T3 PL 12752403 T PL12752403 T PL 12752403T PL 12752403 T PL12752403 T PL 12752403T PL 2682409 T3 PL2682409 T3 PL 2682409T3
- Authority
- PL
- Poland
- Prior art keywords
- derivative
- amino
- carboxylic acid
- hyaluronic acid
- modified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011046749 | 2011-03-03 | ||
| EP12752403.1A EP2682409B1 (en) | 2011-03-03 | 2012-03-02 | Derivative of hyaluronic acid modified with amino-carboxylic acid |
| PCT/JP2012/055421 WO2012118189A1 (ja) | 2011-03-03 | 2012-03-02 | アミノ－カルボン酸により修飾されたヒアルロン酸誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2682409T3 true PL2682409T3 (pl) | 2017-12-29 |
Family
ID=46758114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12752403T PL2682409T3 (pl) | 2011-03-03 | 2012-03-02 | Pochodna kwasu hialuronowego zmodyfikowana kwasem aminokarboksylowym |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9243077B2 (pl) |
| EP (2) | EP3184553B1 (pl) |
| JP (2) | JP6141180B2 (pl) |
| DK (1) | DK2682409T3 (pl) |
| ES (1) | ES2635087T3 (pl) |
| HU (1) | HUE033169T2 (pl) |
| PL (1) | PL2682409T3 (pl) |
| SI (1) | SI2682409T1 (pl) |
| WO (1) | WO2012118189A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104603156B (zh) * | 2012-09-05 | 2016-10-26 | 中外制药株式会社 | 引入有氨基酸和甾基的透明质酸衍生物 |
| US9572832B2 (en) * | 2013-08-29 | 2017-02-21 | Holy Stone Healthcare Co., Ltd. | Compound of glycosaminoglycan and its fabrication method as well as application |
| JP6692051B2 (ja) * | 2015-02-27 | 2020-05-13 | 学校法人常翔学園 | 膜透過性ペプチド鎖を有する多糖誘導体 |
| JP6613300B2 (ja) * | 2015-03-31 | 2019-11-27 | キユーピー株式会社 | ヒアルロン酸誘導体およびその製造方法、ならびにヒアルロン酸誘導体を含む化粧料、食品組成物および医薬組成物 |
| EP3252080A1 (en) * | 2016-05-31 | 2017-12-06 | Galderma S.A. | Method for preparing acylated crosslinked glycosaminoglycans |
| PL3397651T3 (pl) | 2015-12-29 | 2021-02-08 | Galderma S.A. | Węglowodanowy środek sieciujący |
| PT3623390T (pt) * | 2016-05-31 | 2023-10-27 | Galderma Sa | Reticulador de hidrato de carbono |
| CN110891611B (zh) | 2017-03-22 | 2024-03-29 | 阿森迪斯制药公司 | 水凝胶交联透明质酸前药组合物和方法 |
| US11512147B2 (en) | 2017-11-15 | 2022-11-29 | Chugai Seiyaku Kabushiki Kaisha | Hyaluronic acid derivative modified with polyethylene glycol |
| CN109206537B (zh) * | 2018-10-10 | 2021-04-09 | 华熙生物科技股份有限公司 | 一种乙酰化透明质酸钠的制备方法及其应用 |
| KR20220110786A (ko) | 2019-12-02 | 2022-08-09 | 갈더마 홀딩 소시에떼 아노님 | 고분자량 에스테틱 조성물 |
| CN116507575A (zh) | 2020-11-12 | 2023-07-28 | 三菱电机株式会社 | 乘客输送机的栏杆 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174999B1 (en) | 1987-09-18 | 2001-01-16 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
| US6610669B1 (en) | 1987-09-18 | 2003-08-26 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
| US4937270A (en) * | 1987-09-18 | 1990-06-26 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
| JP2766303B2 (ja) | 1989-04-13 | 1998-06-18 | 生化学工業株式会社 | グリコサミノグリカンで修飾されたスーパーオキシドジスムターゼ及びその製造法 |
| AU652784B2 (en) | 1990-10-18 | 1994-09-08 | Shiseido Company Ltd. | Combination of hyaluronic acid with medicinal ingredient and production thereof |
| JPH0585942A (ja) | 1991-02-26 | 1993-04-06 | Denki Kagaku Kogyo Kk | インターフエロン−ヒアルロン酸及び／又はその塩の結合体 |
| JP4018181B2 (ja) * | 1995-11-07 | 2007-12-05 | 生化学工業株式会社 | グリコサミノグリカン誘導体およびその製造法 |
| KR20010032879A (ko) | 1997-12-12 | 2001-04-25 | 익스프레션 제네틱스, 인코퍼레이티드 | 유전자 담체로서 융합된 공중합체 |
| ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
| US6630457B1 (en) * | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
| WO2001005434A2 (en) | 1999-07-20 | 2001-01-25 | Amgen Inc. | Hyaluronic acid-protein conjugates |
| JP2001081103A (ja) | 1999-09-13 | 2001-03-27 | Denki Kagaku Kogyo Kk | ヒアルロン酸結合薬剤 |
| WO2001060412A2 (en) | 2000-02-15 | 2001-08-23 | Genzyme Corporation | Modification of biopolymers for improved drug delivery |
| EP1666518B1 (en) * | 2003-09-08 | 2018-03-28 | Chugai Seiyaku Kabushiki Kaisha | Hyaluronic acid modification products and drug carriers using them |
| TW200526253A (en) | 2003-11-14 | 2005-08-16 | Chugai Pharmaceutical Co Ltd | Cross-linked polysaccharide microparticles and process for producing the same |
| JPWO2005054302A1 (ja) | 2003-12-05 | 2007-12-06 | 中外製薬株式会社 | 薬物担体及びその製造方法 |
| WO2006028110A1 (ja) | 2004-09-07 | 2006-03-16 | Chugai Seiyaku Kabushiki Kaisha | 水溶性ヒアルロン酸修飾物の製造方法 |
| TW200643033A (en) | 2005-03-08 | 2006-12-16 | Chugai Pharmaceutical Co Ltd | Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue |
| CN101679321B (zh) * | 2007-04-30 | 2012-10-03 | 普罗米蒂克生物科学公司 | 三嗪衍生物、含所述衍生物的组合物以及所述衍生物在制备用于治疗癌症和自身免疫性疾病药物中的应用 |
| JP5542687B2 (ja) | 2008-11-05 | 2014-07-09 | 国立大学法人 東京医科歯科大学 | ヒアルロン酸誘導体、およびその医薬組成物 |
| IT1399351B1 (it) * | 2009-06-16 | 2013-04-16 | Fidia Farmaceutici | Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi |
| WO2011148116A2 (fr) | 2010-05-27 | 2011-12-01 | Laboratoire Idenov | Acide hyaluronique modifie, procede de fabrication et utilisations |
-
2012
- 2012-03-02 WO PCT/JP2012/055421 patent/WO2012118189A1/ja active Application Filing
- 2012-03-02 PL PL12752403T patent/PL2682409T3/pl unknown
- 2012-03-02 EP EP17152228.7A patent/EP3184553B1/en active Active
- 2012-03-02 EP EP12752403.1A patent/EP2682409B1/en active Active
- 2012-03-02 DK DK12752403.1T patent/DK2682409T3/en active
- 2012-03-02 HU HUE12752403A patent/HUE033169T2/en unknown
- 2012-03-02 SI SI201231008T patent/SI2682409T1/sl unknown
- 2012-03-02 JP JP2013502420A patent/JP6141180B2/ja active Active
- 2012-03-02 ES ES12752403.1T patent/ES2635087T3/es active Active
- 2012-03-02 US US14/002,919 patent/US9243077B2/en active Active
-
2017
- 2017-05-01 JP JP2017091352A patent/JP2017179374A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3184553B1 (en) | 2019-05-01 |
| EP2682409A1 (en) | 2014-01-08 |
| JP6141180B2 (ja) | 2017-06-07 |
| JPWO2012118189A1 (ja) | 2014-07-07 |
| WO2012118189A1 (ja) | 2012-09-07 |
| EP3184553A1 (en) | 2017-06-28 |
| JP2017179374A (ja) | 2017-10-05 |
| US9243077B2 (en) | 2016-01-26 |
| US20130338352A1 (en) | 2013-12-19 |
| ES2635087T3 (es) | 2017-10-02 |
| EP2682409A4 (en) | 2014-11-19 |
| EP2682409B1 (en) | 2017-07-05 |
| DK2682409T3 (en) | 2017-09-11 |
| HUE033169T2 (en) | 2017-11-28 |
| SI2682409T1 (sl) | 2017-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2682409T3 (pl) | Pochodna kwasu hialuronowego zmodyfikowana kwasem aminokarboksylowym | |
| SG11201500187WA (en) | Methods of manufacturing cartilage products | |
| EP2712362A4 (en) | MANUFACTURE OF LACTO-N-TETRAOSE | |
| GB201104096D0 (en) | Production of graphene | |
| IL232230A0 (en) | Derivation of aminoalkyl substituted n-thianylbenzamide | |
| GB201103499D0 (en) | Process | |
| EP2798063A4 (en) | PREPARATION OF DIHYDROSTERCULINIC ACID AND DERIVATIVES THEREOF | |
| ZA201402377B (en) | Electrolytic production of power | |
| SG10201604562PA (en) | Biotechnological production of 3-hydroxyisobutyric acid | |
| GB201101370D0 (en) | Process | |
| HK1207112A1 (en) | Methods of production of products of metabolic pathways | |
| GB201410312D0 (en) | Photobioreactor | |
| SG2014010441A (en) | Preparation process of l-methionine | |
| GB2507679B (en) | Nanostructure tracking of products | |
| ZA201309109B (en) | Methods of treating biomass | |
| GB201104469D0 (en) | Control of phagocytosis | |
| ZA201400918B (en) | Pyrrolidine-3-ylacetic acid derivative | |
| EP2768941A4 (en) | photobioreactor | |
| GB201103092D0 (en) | Process | |
| EP2782902A4 (en) | DERIVATIVES FROM PHENOXYISOBUTTERIC ACID | |
| ZA201307229B (en) | Prodrugs of d-isoglutamyl-[d/l]- tryprophan | |
| GB201114798D0 (en) | Method of modifying surfaces | |
| GB201119607D0 (en) | Method of manufacture | |
| GB2494923B (en) | Set of support assemblies | |
| EP2799424A4 (en) | 2-FLUORPHENYLPROPIONSÄUREDERIVAT |